Interactive Brokers Advertisement
Home > Boards > Canadian > Medical - Drugs >

Syndax Pharmaceuticals Inc (SNDX)

Add SNDX Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 5/17/2017 10:39:38 AM - Followers: 2 - Board type: Free - Posts Today: 0

Syndax Pharmaceuticals, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is focused on the development of entinostat as a combination therapy in multiple cancer indications with a focus on tumors that are sensitive to immunotherapy, including lung cancer, melanoma, ovarian cancer and triple-negative breast cancer (TNBC). The Company is also developing Entinostat as a combination therapeutic in a Phase III clinical trial, which is being conducted with ECOG-ACRIN for advanced hormone receptor positive (HR+) breast cancer. The Company's Entinostat is an oral, small molecule histone deacetylase (HDAC) inhibitor that has direct effects on both cancer cells and immune regulatory cells, and also enhances the body’s immune response to tumors. The Company's product pipeline for immune-oncology includes ENCORE 601, ENCORE 602, ENCORE 603, J1353, NCI-7870 and NCI-9844. Its pipeline for advanced HR+ breast cancer includes E2112.
Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SNDX News: Current Report Filing (8-k) 10/20/2017 05:21:52 PM
SNDX News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 10/18/2017 12:14:01 PM
SNDX News: Current Report Filing (8-k) 10/17/2017 07:38:25 AM
SNDX News: Syndax Announces $25 Million Registered Direct Offering of Common Stock 10/17/2017 07:01:00 AM
SNDX News: Syndax Expands Pipeline with Exclusive Worldwide License to Allergan's Portfolio of Menin-MLL Inhibitors 10/17/2017 07:00:00 AM
#4   Damn Awl416 05/17/17 10:39:38 AM
#3   I got this on my radar. I love the ~Nautical~ 03/24/16 09:13:34 PM
#2 T695 03/10/16 05:35:19 PM
#1   SNDX had a nice pull back today abs T695 03/10/16 05:31:07 PM